The Legal 500

United States

United States > Litigation > Mass tort and class action: plaintiff representation – pharmaceuticals and medical devices

Editorial

Index of tables

  1. Mass tort and class action: plaintiff representation – pharmaceuticals and medical devices
  2. Leading lawyers

Leading lawyers

    • Andy Birchfield Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.
    • Michael Burg Burg Simpson Eldredge Hersh & Jardine, P.C.
    • Russ Herman Herman, Herman & Katz LLC
    • W. Mark Lanier The Lanier Law Firm
    • Mike Papantonio Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A.
    • Michelle Parfitt Ashcraft & Gerel LLP
    • Christopher Seeger Seeger Weiss LLP

The ‘excellentBurg Simpson Eldredge Hersh & Jardine, P.C. is ‘one of the leaders in this field’ and is praised for ‘seeing a case through to trial if necessary’. The firm remains involved in the Yaz /Yasmin multi-district litigation (MDL), where practice head Michael Burg is co-lead counsel, Seth Katz serves as the chair of the discovery committee and Janet Abaray is co-chair of the science and expert committee. In 2013 the firm was also involved in negotiating a global settlement with Bayer with regard to gall bladder injuries; it recently entered into negotiations with the company regarding compensation for venous injuries suffered by over 8000 women. Katz, who is particularly ‘strong on electronic discovery’, is currently serving as co-lead counsel in the Pradaxa litigation, and is also a member of the plaintiffs’ steering committee in the MDL involving DePuy Orthopaedics’ recalled ASR XL metal-on-metal hip device and the alleged failure of its ASR XL Acetabular Hip System. Abaray is the lead attorney in the Depakote products liability claims, where depositions are ongoing and expert witnesses have been retained. Michael Burg and Peter Burg ‘are experienced and highly capable trial lawyers who are absolutely devoted to their clients and practices’.

Herman, Herman & Katz LLC has an active practice operating out of New Orleans. The firm is currently representing plaintiffs in Granuflo litigation against Fresenius Medical Care; the case was established as an MDL in 2013, with James Klick serving on the plaintiffs’ executive committee and of counsel Joseph Kott serving as co-chair of the science committee. The firm is also active in the TYLENOL MDL, with Leonard Davis serving on the plaintiffs’ steering committee, and its role in the Vioxx litigation recently saw it negotiating a $23m settlement for the reimbursement of prescription costs; Russ Herman serves as the plaintiffs’ liaison counsel and chair of the executive committee, Davis is an ex-officio member of the plaintiffs’ steering committee and Stephen Herman is co-chair of the sales and marketing committee, insurance committee and a member of the drafting team.

The ‘highly regardedLevin Papantonio Thomas Mitchell Rafferty & Proctor, P.A. is headquartered in northwest Florida, and its track record includes handling litigation involving Actos, Accutane, GranuFlo, antidepressants and DePuy hip implants; in the latter, Ben Gordon serves on the plaintiffs’ executive committee and has been appointed as co-chair of the science and expert committee. Other key names in the team Troy Rafferty and Timothy O’Brien are involved in the gadolinium-based contrast agent litigation and Fosamax product liability litigation respectively. Mike Papantonio is a ‘good trial lawyer’.

Lieff Cabraser Heimann & Bernstein, LLP is ‘very good’, particularly in hip replacement cases; it remains active in the DePuy artificial hip litigation, where Wendy Fleishman serves on the plaintiffs’ steering committee in the MDL and Robert Nelson serves on the plaintiffs’ steering committee in co-ordinated proceedings in the California state court. Other activities in 2013 included filing claims in the Medtronic InFUSE litigation, where injuries are alleged to have arisen from the off-label use of the InFUSE bone graft. The firm is also active in pharmaceutical litigation such as the Actos litigation; Donald Arbitblit serves on the science committee. Practice head Elizabeth Cabraser is a ‘stand-out name’ in this area. Cabraser, Arbitblit and Nelson are based in the firm’s San Francisco office, while Fleishman is New York-based.

Name partner W Mark Lanier at The Lanier Law Firm is a ‘major player’; opponents note that when this ‘formidable’ attorney is on the other side that they ‘stand up and take notice’. The firm, which has offices in Texas, California and New York, has represented clients in litigation involving DePuy hip replacements, transvaginal mesh, failed knee replacements, CHANTIX and Paxil. The firm is currently representing plaintiffs in claims against Intuitive Surgical, which manufactures the da Vinci Surgical Robot, for failure to properly train surgeons on the proper use of the product; plaintiffs claim to have suffered injuries following surgery involving the Robot, including tears or burns to blood vessels, intestines and other internal organs. New York-based pharmaceutical litigation chair Richard Meadow continues to serve on a number of plaintiffs’ steering committees.

The ‘very professional’ team at Levin, Fishbein, Sedran & Berman is praised by peers for ‘getting the ball moving’ in litigation and is ‘fabulous in pulmonary hypertension cases’. The firm is currently lead plaintiffs’ counsel in the nationwide class action concerning diet drugs, representing clients in both the trial and appellate courts. The ‘excellent’ Arnold Levin serves on the negotiating plaintiffs’ counsel committee in the Vioxx litigation. Frederick Longer and Michael Fishbein are also recommended. The team is based in the firm’s sole office in Philadelphia.

Seeger Weiss LLP’s ‘very active’ team is made up of ‘civil, ethical lawyers who do their job well’; it operates from offices in New York, New Jersey and Pennsylvania. Co-founder Christopher Seeger is a ‘very good organizer’ and continues to act in MDLs; for example he is on the plaintiffs’ steering committee in the Actos litigation, and has been appointed to the plaintiffs’ executive committee in the the DePuy artificial hip litigation. David Buchanan, who is ‘excellent’, is noted for his expertise in electronic discovery.

Ashcraft & Gerel LLP’s 20 fee-earner team operates from offices in Washington DC, Virginia and Maryland. It represents plaintiffs in litigation involving Actos, the da Vinci Surgical System, GranuFlo, Pradaxa and TYLENOL. Michelle Parfitt and James Green in the firm’s Washington DC office are ‘top names’ in this area; the latter has been appointed to serve on the MDL committees for prescription drugs including Fosamax, Rezulin and Zyprexa.

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., which is based in Montgomery, Alabama, is praised by peers for its ‘good work’. Highlights included Frank Woodson’s appointment to serve on the plaintiffs’ steering committee for the GranuFlo litigation and Roger Smith’s appointment to serve on the plaintiffs’ steering committee for the Mirena IUD litigation. Andy Birchfield heads the mass torts practice, which includes P Leigh O’Dell, and which has recently added seven of counsel.

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • MD: Finally! Liquidating a Company is Now a Mission Possible

    On 29 May 2014, the Moldovan Parliament passed the Act No. 90/2014 on amending and supplementing of certain legislative acts (Act No. 90). Act No.90, which entered into force on 27 June 2014, implements simplified rules on the liquidation of companies in Moldova (in particular, at the decision of their shareholders), namely by inter alia amending the Civil Code of Moldova, Act No. 845/1992 on Entrepreneurship and Enterprises, Act No. 220/2007 on State Registration of Companies and Individual Entrepreneurs.  read more...
  • How to Hire and Fire: A Global Guide 2014

    Multilaw's Labour & Employment practice group has produced a new 2014 edition of "How to Hire and Fire: A Global Guide." With content contributed by experienced employment lawyers from Multilaw member firms, the eBook provides a simple way for HR practitioners and clients to get a quick, uncomplicated overview of basic employment law information from jurisdictions around the world. The book reflects the law in each jurisdiction as of January 1, 2014. Jurisdictions covered by the 2014 edition include Argentina, Belgium, Bulgaria, Canada, China, Cyprus, Ecuador, European Union, Germany, Honduras, Hong Kong, India, Indonesia, Italy, Japan, Luxembourg, Malaysia, Netherlands, Oman, Paraguay, and Philippines, among others. The Philippine chapter was written by SyCipLaw partner  Leslie C. Dy . Visit the Multilaw website to access and download the file:  www.multilaw.com/hire-and-fire/#2-3 .
  • How Can Turkish Banking Cope with the Changing Global Banking Dynamics?

    2008 global economic meltdown had served as an important wake up call for the global banking industry. The complicated web of interrelated financial instruments created by investment banking gurus, accompanied by a lax regulatory regime came to create one of the biggest financial disasters after the Great Depression and itself termed by many as the Great Recession costing millions of people their savings, jobs and houses.
  • American Defense Industry: Does the Legal Regime Hamstring the Business?

    The United States is still by far the leading country in defense spending, allocating a sizable portion of its GDP to produce cutting edge military technologies. However recent reports indicate a decline in American exports in military hardware. There are not only reports that point to an under-funding of procurement around USD$ 50 billion on an annual basis but also a general complaint on the part of the key players of the industry regarding the restrictive export regime that impedes the sale of military equipment to the non-American parties.
  • GSK Advises EnBW AG on Acquisition of Eni’s Joint Venture Holdings in Gas Business

    EnBW Energie Baden-Württemberg AG (EnBW) is acquiring the 50%  holdings of Eni Gruppe, Rome, in EnBW Eni Verwaltungsgesellschaft mbH, Stuttgart, thereby increasing its holdings to 100 %. This makes EnBW indirectly the sole shareholder of Gasversorgung Süddeutschland GmbH (GVS) and terranets bw GmbH. GSK Stockmann + Kollegen provided comprehensive legal advice to EnBW in connection with this transaction.
  • Transition to electronic meal vouchers - Paper meal vouchers disappear on 1 January 2016

    Aware of the advantages of meal vouchers in electronic form, the Government has decided to definitively replace the paper form by electronic form, with effect from 1 January 2016.
  • CSSF issues circular on investor notification of material changes to open-ended UCITS funds

    Luxembourg's Financial Sector Supervisory Authority According has published Circular 14/591 on July 22, addressed to all open-ended UCITS funds governed by the grand duchy's legislation of December 17, 2010, regarding the protection of investors in the event of a material change to an open-ended undertaking for collective investment. The CSSF says that according to well-established supervisory practice, in the event of such a material change to investors' interests in an open-ended fund under the 2010 law, the regulator requires that they be given sufficient time to take an informed decision, and that if they do not wish to accept the proposed change, they should be able to redeem or convert their shares or units free of charges.
  • Newsflash -Restrictive measures recently adopted against the Russian Federation

    In response to the downing of the Malaysian Airlines Flight MH17 in Donetsk and in view of the gravity of the overall situation, the Council of the European Union has adopted new restrictive measures targeting cooperation and exchanges with the Russian Federation. 2014.08.05_-_russian_sanctions_newsflash
  • TTIP: The Issue of Investor to State Dispute Settlements

    The benefits that will the TTIP bring in to the table for both of the signatories across the Atlantic are well documented by the Atlantic Community. Generation of a volume trade that amounts a USD$ 1.2 billion and the expansion of the already existing transatlantic trade accompanied by the removal of non-tariff barriers as well as cheaper prices for the consumers and common standards for the producers that would give a leeway for them in fierce global competition by declining production costs. However the other side of the coin points to possible pitfalls for the TTIP like a requirement for a painstaking process of harmonization of two different legal systems and possible discords regarding the inclusion and exclusion of some specific sectors in to the agreement. However one of those prospective challenges has increasingly coming to the fore and lately being discussed among the pundits as one of the most troublesome among the others. This is the point concerning the investor to state dispute settlements ( ISDS )
  • GSK Advises PAMERA Real Estate Group on the Sale of the PAMERA Companies to Cornerstone Group

    GSK Stockmann + Kollegen advised the shareholder of the PAMERA Asset Management GmbH, the PAMERA Retail GmbH and the PAMERA Development GmbH on the sale of these companies to the European Cornerstone subsidiary of US-American Cornerstone Estate Advisers LLC.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to